|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 5B: Effects of hypokalemia on RR interval duration (msec) during sinus rhythm, ventricular tachicardia, third-degree AV block. BPC 157 (intraperitoneally or intragastrically) as a therapy, after furosemide (100 mg/kg intraperitoneally), when hypokalemia- third-degree AV block and ventricular tachycardia were already established. Values are mean ± SEM. ¥ - Two-way ANOVA with repeated measure on one factor (P<0.05) difference between measurements depends on group membership. †P<0.05 significantly different from control values. |